Recro Pharma: 4Q Earnings Snapshot

February 19, 2019

MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Tuesday reported a loss of $41.3 million in its fourth quarter.

The Malvern, Pennsylvania-based company said it had a loss of $1.92 per share. Losses, adjusted for pretax expenses, came to 58 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 74 cents per share.

The specialty pharmaceutical company posted revenue of $17.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $16 million.

For the year, the company reported that its loss widened to $79.7 million, or $3.90 per share. Revenue was reported as $77.3 million.

Recro Pharma shares have climbed 22 percent since the beginning of the year. The stock has climbed 4.5 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH